ARTICLE | Distillery Techniques
Biomarkers
August 23, 2018 5:05 PM UTC
A three-protein signature in tumor-infiltrating lymphocytes (TILs) could help predict response to PD-1 and PD-L1 inhibitors in NSCLC. In pre-treatment tumor samples from 39 NSCLC patients treated with...